MedPath

The measurement of insulin sensitivity index in normoglycemic healthy Korean subjects

Not Applicable
Completed
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0003156
Lead Sponsor
Gachon University Gil Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
30
Inclusion Criteria

1) Korean aged 50-69 years old
2) body weight 50kg or more with body mass index (kg/m2) 18.5-28
3) no congenital or systemic illnesses requiring medical care
4) no significant abnormal results on screening tests which included routine blood test and blood chemistry, urine test, ECG and physical examinations
5) subjects who provided written informed consent

Exclusion Criteria

1)Subjects with impaired fasting glucose, impaired glucose tolerance, or diabetes or subjects on medical therapy for diabetes
2)Subjects who have hypersensitivity to insulin or preservatives of insulin
3)Subjects with specific diseases in hepatobiliary, renal, or cardiovascular systems, with endocrine disease, or with other systemic illnesses
4)active liver diseases or liver transaminase enzyme levels elevated more than twofold the upper limit of normal
5) patients with known hypertension or subjects with blood pressure levels of > 160/90 mmHg or < 90/60 mmHg.
6) systemic diseases or injury within 12 weeks
7) other study medication or intervention therapy within 3 months before oral glucose tolerance test
8) Positive result on tests for HBs antigen, HCV antibody, or HIV antibody
9) any other issue suggesting that study participation seems to be inappropriate

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
glucose disposal rate (mg/kg/min)
Secondary Outcome Measures
NameTimeMethod
2 hour-glucose level after oral glucose loading (75grams)
© Copyright 2025. All Rights Reserved by MedPath